# Dose Modification Requirement for Trelagliptin in Egyptian Population

> **NCT04374864** · PHASE4 · UNKNOWN · sponsor: **British University In Egypt** · enrollment: 6 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Trelagliptin

## Key facts

- **NCT ID:** NCT04374864
- **Lead sponsor:** British University In Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2020-05-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04374864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04374864, "Dose Modification Requirement for Trelagliptin in Egyptian Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04374864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*